Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Scott

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
European Journal of Pediatrics|October 12, 2013
Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoinC Breen, F J White, C A B Scott, et al.
Diabetes Research and Clinical Practice|October 9, 2020
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trialMalgorzata Wamil, John J V McMurray, Charles A B Scott, et al.
Diabetes, Obesity & Metabolism|April 24, 2026
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisJoão Sérgio Neves, Ana Rita Leite, Francisco Vasques-Nóvoa, et al.
Nature Communications|February 23, 2023
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trialNantia Othonos, Riccardo Pofi, Anastasia Arvaniti, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
European Journal of Pediatrics|October 12, 2013
Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoinC Breen, F J White, C A B Scott, et al.
Diabetes Research and Clinical Practice|October 9, 2020
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trialMalgorzata Wamil, John J V McMurray, Charles A B Scott, et al.
Diabetes, Obesity & Metabolism|April 24, 2026
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisJoão Sérgio Neves, Ana Rita Leite, Francisco Vasques-Nóvoa, et al.
Nature Communications|February 23, 2023
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trialNantia Othonos, Riccardo Pofi, Anastasia Arvaniti, et al.
Pageof 10